Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 6:27 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 517 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Sepsis Clear all

Conditions: Infection Associated With Catheter, Bacteremia, Sepsis
Interventions: Ethanol lock, Heparinized saline; Drug
Lead sponsor: East Carolina University; Other
Eligibility: Up to 32 Weeks
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 1
States / cities: Greenville, North Carolina

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Sepsis
Interventions: IVIG, Placebo; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 72 Hours
Enrollment: 2,416 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1988 – 1991
U.S. locations: 8
States / cities: Birmingham, Alabama • Washington D.C., District of Columbia • Miami, Florida + 5 more

Conditions: Exercise Program, Standard Care Control
Interventions: App-based exercise program, Standard of Care; Other
Lead sponsor: University of Florida; Other
Eligibility: 55 Years to 105 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Sepsis, Sepsis Mrsa, Sepsis Bacteremia, Antimicrobial - Induced Nephropathy, Sepsis, Severe, Septic Shock, Septic Syndrome
Interventions: Multifaceted de-implementation strategy to reduce vancomycin overuse; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: Not listed
Enrollment: 52,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 4
States / cities: Atlanta, Georgia • Baltimore, Maryland • St Louis, Missouri + 1 more

Conditions: Sepsis
Interventions: Telemedicine; Other
Lead sponsor: Nicholas M Mohr; Other
Eligibility: 18 Years and older
Enrollment: 55,772 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Septic Shock, Sepsis
Interventions: Immediate evaluation by multidisciplinary team; Other
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 3,230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 4
States / cities: Murray, Utah • Riverton, Utah • Salt Lake City, Utah + 1 more

Conditions: Sepsis
Interventions: ClearSight™ / EV1000NI Clinical Platform; Device
Lead sponsor: Edwards Lifesciences; Industry
Eligibility: 18 Years and older
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 5
States / cities: Detroit, Michigan • Royal Oak, Michigan • Troy, Michigan

Conditions: Pediatric Sepsis-induced MODS
Interventions: GM-CSF; Drug
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: Up to 17 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 8
States / cities: Los Angeles, California • San Francisco, California • Aurora, Colorado + 5 more

Conditions: Sepsis, Congenital Diaphragmatic Hernia, Neonatal Cardiopulmonary Failure
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: Up to 2 Months
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Salt Lake City, Utah

Conditions: Acinetobacter Infections
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2017
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Pneumonia, Blood Stream Infection, Urinary Tract Infections, Respiratory Tract Infection (Including Tracheobronchitis), Sepsis
Interventions: Not listed
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 3
States / cities: Chicago, Illinois • New York, New York

Conditions: Infection, Enterocolitis, Necrotizing, Ventilator-associated Pneumonia
Interventions: oropharyngeal mother's milk, oropharyngeal sterile water; Other
Lead sponsor: Endeavor Health; Other
Eligibility: 1 Day to 4 Days
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2022
U.S. locations: 5
States / cities: Miami, Florida • Evanston, Illinois • Park Ridge, Illinois + 2 more

Conditions: Sepsis, Acute Kidney Injury
Interventions: AZD4144, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 16
States / cities: Phoenix, Arizona • Newport Beach, California • Kansas City, Kansas + 11 more

Conditions: Surgical Site Infection
Interventions: Chlorhexidine - Isopropyl alcohol, Povidone-Iodine Scrub and Paint; Drug
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 932 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Preeclampsia, Eclampsia, HELLP Syndrome, Toxemia, Hypertensive Disorder of Pregnancy
Interventions: Not listed
Lead sponsor: Preeclampsia Foundation; Other
Eligibility: 13 Years and older
Enrollment: 20,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2040
U.S. locations: 1
States / cities: Melbourne, Florida

Conditions: Hyperglycemia, Sepsis
Interventions: Dopamine; Drug
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years to 35 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Sepsis, Acute Lung Injury, Acute Respiratory Distress Syndrome
Interventions: ALT-836, Placebo; Drug
Lead sponsor: Altor BioScience; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 20
States / cities: Los Angeles, California • Sacramento, California • Stanford, California + 15 more

Conditions: Bloodstream Infection
Interventions: GARNET device; Device
Lead sponsor: Boa Biomedical, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 6
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Bethesda, Maryland + 3 more

Conditions: Sepsis, Septic Shock, Acute Kidney Injury, Metformin
Interventions: Metformin low dose, Metformin high dose, Placebo; Drug
Lead sponsor: Hernando Gomez; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: New Onset Atrial Fibrillation, Severe Sepsis, Septic Shock
Interventions: Amiodarone; Drug
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Sepsis, Acute Infection
Interventions: Not listed
Lead sponsor: MeMed Diagnostics Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 2
States / cities: New York, New York • Milwaukee, Wisconsin

Conditions: Severe Sepsis, Septic Shock
Interventions: NICOM/FloTrac, Crystalloid Fluid Challenge; Device · Other
Lead sponsor: Santa Barbara Cottage Hospital; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Santa Barbara, California

Conditions: Sepsis, Septic Shock, Severe Sepsis
Interventions: Severe Sepsis Prediction, Severe Sepsis Detection; Other
Lead sponsor: Dascena; Industry
Eligibility: 18 Years and older
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2016
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Septic Shock, Severe Sepsis
Interventions: Intravenous Fluid Cap; Other
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Providence, Rhode Island

Search by objective public record fields.

Safety and Efficacy Study of Ethanol Locking to Prevent Central Line Infection in Premature Neonates

Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection

Home-based Digital Exercise Training Program to Improve Physical Function of Older Sepsis Survivors - HEAL Sepsis Trial

Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis

Evaluating Tele-Emergency Care in Costs and Outcomes for Rural Sepsis Patients

Effect of Emergency Department Care Reorganization on Door-to-antibiotic Times for Sepsis (LDS SWARM)

CLEAR Sepsis Clinical Study

GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study

Inflammatory Cytokine Quantification in Infants

Clinical Outcomes and Global Epidemiology -Data Coordinating Center

Optimizing Clinical Use of Polymyxin B

Oropharyngeal Administration of Mother's Colostrum for Premature Infants (NS-72393-360)

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

Chlorhexidine-Alcohol Versus Povidone-Iodine for Cesarean Antisepsis

The Preeclampsia Registry

Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects

Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome

GARNET™ Filter (GARNET Device) IDE Used in Chronic Hemodialysis Patients With a Bloodstream Infection

Safety and Feasibility of Metformin for Sepsis Induced AKI

Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock

A Multicenter Prospective Observational Study to Derive and Verify the Performance of a Host-response Based Diagnostic Tool for Early Detection of Severe Infections.

Monitoring Devices in Prediction of Fluid Responsiveness in Severe Sepsis and Septic Shock

An Algorithm Driven Sepsis Prediction Biomarker

Restrictive Intravenous Fluids Trial in Sepsis